IMVAMUNE DIN 02416638
Status: Restricted Access
Holder: BAVARIAN NORDIC AS
Health Canada record
| Active ingredient(s) | MODIFIED VACCINIA VIRUS (ANKARA-BAVARIAN NORDIC) 50000000 CCID50 |
|---|---|
| Dosage form | Suspension |
| Route | Subcutaneous |
| Schedule | SCHEDULE D |
| Class | Human |
| ATC | J07BX01 SMALLPOX AND MPOX VACCINES |
| Original market date | 15-Jun-2015 |
| Current status date | 29-May-2023 |
| Source | Health Canada DPD |
Establishment licence of the holder
Bavarian Nordic GmbH — licence , not currently licensed, last inspection rating I (2026-06-10).
No Canadian shortage report is currently matched to this DIN.
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 14918 | 2013-11-21 | New Drug Submission (NDS) |